Skip to content

Drug-Related Problems : Focus on Age and Diabetes

Observatory of Drug-Related Problems: Impact of the Age and the Presence of Diabetes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04692220
Acronym
DRP-AD
Enrollment
27000
Registered
2020-12-31
Start date
2011-11-01
Completion date
2021-03-30
Last updated
2021-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Drug Events

Keywords

Drug-Related Problems, Clinical Pharmacist, Elderly, Diabetes

Brief summary

Drug-Related Problems (DRP) are a variety of events or circumstances that can interfere with the expected results of a treatment. They may be due to the drug itself, its association with other treatments, its incompatibility with the patient, its misuse... When these situations result in harm, they are referred to as adverse drug events (ADEs). DRP and particularly ADE represent a major public health problem in healthcare institutions because of their impact on morbidity and health costs. DRPs are largely preventable and actions can be set up to detect and correct them. It is in this context that clinical pharmacy has expanded, with the development of new activities to help secure drug management. In our institution, the investigators have implemented several activities in different care services, including * medication reconciliation, * an ADE detection. These activities have interesting and encouraging results in terms of impact on the prevention of DRP. However, they can only be carried out on a limited number of patients, depending on the pharmaceutical resources available. The investigators therefore need tools to prioritize our activities on the most at-risk patients. In this study, the investigators seek to identify DRP risk factors and develop DRP risk scores, with the objective to improve the detection and even prevention of DRP. Translated with www.DeepL.com/Translator (free version)

Interventions

OTHERDetection of Adverse Drug Events or Drug-Related Problems

Detection of Adverse Drug Events or Drug-Related Problems

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- Patients aged above 18 years old, admitted to the emergency department or hospital

Exclusion criteria

* Patients presenting acute psychological disturbance * Patients that did not agree to participate

Design outcomes

Primary

MeasureTime frameDescription
Variables associated with the presence of an Adverse Drug Events or Drug-Related Problems1 dayVariables associated with the presence of an Adverse Drug Events or Drug-Related Problems

Secondary

MeasureTime frameDescription
Number and type of Adverse Drug Events and Drug-Related Problems1 dayNumber and type of Adverse Drug Events and Drug-Related Problems

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026